DK0712931T4 - Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma - Google Patents

Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma

Info

Publication number
DK0712931T4
DK0712931T4 DK95308055T DK95308055T DK0712931T4 DK 0712931 T4 DK0712931 T4 DK 0712931T4 DK 95308055 T DK95308055 T DK 95308055T DK 95308055 T DK95308055 T DK 95308055T DK 0712931 T4 DK0712931 T4 DK 0712931T4
Authority
DK
Denmark
Prior art keywords
interferon
gamma
agent
monoclonal antibody
inducing polypeptide
Prior art date
Application number
DK95308055T
Other languages
Danish (da)
English (en)
Other versions
DK0712931T3 (da
Inventor
Kakuji Torigoe
Tadao Tanimoto
Shigeharu Fukuda
Masashi Kurimoto
Shimpei Ushio
Haruki Okamura
Toshio Kunikata
Mutsuko Taniguchi
Keizo Kohno
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27523434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0712931(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP7058240A external-priority patent/JP2952750B2/ja
Priority claimed from JP7262062A external-priority patent/JP2724987B2/ja
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Application granted granted Critical
Publication of DK0712931T3 publication Critical patent/DK0712931T3/da
Publication of DK0712931T4 publication Critical patent/DK0712931T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95308055T 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma DK0712931T4 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30420394 1994-11-15
JP7058240A JP2952750B2 (ja) 1995-02-23 1995-02-23 モノクローナル抗体
JP7835795 1995-03-10
JP7262062A JP2724987B2 (ja) 1994-11-15 1995-09-18 インターフェロン−γの産生を誘導するポリペプチド
JP27498895 1995-09-29

Publications (2)

Publication Number Publication Date
DK0712931T3 DK0712931T3 (da) 2001-03-19
DK0712931T4 true DK0712931T4 (da) 2006-08-21

Family

ID=27523434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95308055T DK0712931T4 (da) 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid

Country Status (7)

Country Link
EP (2) EP0962531B1 (fr)
AU (1) AU700948B2 (fr)
CA (1) CA2162353C (fr)
DE (2) DE69535989D1 (fr)
DK (2) DK0712931T4 (fr)
ES (2) ES2156199T5 (fr)
TW (2) TW464656B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
EP0870028A1 (fr) * 1995-12-29 1998-10-14 Incyte Pharmaceuticals, Inc. Acides nucleiques codant le facteur 2 inducteur de l'interferon gamma
CA2255906A1 (fr) * 1996-05-20 1997-11-27 Schering Corporation Interleukine-1j d'origine humaine et ses antagonistes
EP0816499A3 (fr) * 1996-06-27 1999-10-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ADN génomique codant pour un polypeptide capable d'induire la production d'interféron-gamma
US6790442B1 (en) 1996-06-27 2004-09-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-γ
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
JP3955352B2 (ja) 1997-02-25 2007-08-08 株式会社林原生物化学研究所 破骨細胞形成阻害剤
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
EP1013763B1 (fr) * 1997-08-07 2011-02-02 Toray Industries, Inc. Procédé de production d'interleukine 18 canine
JP2001521906A (ja) * 1997-11-03 2001-11-13 ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー 血管新生を阻害し、癌を処置するための方法及び組成物
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
RU2175554C2 (ru) * 1999-03-30 2001-11-10 Пермское научно-производственное объединение "Биомед" Оральный препарат интерферона в виде таблеток
US6432678B1 (en) 1999-06-21 2002-08-13 Smithkline Beecham Corporation Macaca cynomolgus IL 18
CA2399148A1 (fr) 2000-02-10 2001-08-16 Abbott Laboratories Anticorps de liaison de l'interleukine 18 humaine et procedes de preparation et d'utilisation
GB0009503D0 (en) * 2000-04-17 2000-06-07 Univ Liverpool Screening method for compounds
CN1457258A (zh) * 2000-06-02 2003-11-19 史密丝克莱恩比彻姆公司 用il－18和il－18组合物治疗病毒性疾病的方法
PL366134A1 (en) 2000-06-15 2005-01-24 Smithkline Beecham Corporation Method for preparing a physiologically active il-18 polypeptide
EP2295081B1 (fr) 2001-06-26 2018-10-31 Amgen Inc. Anticorps OPGL
US20040023336A1 (en) * 2001-10-26 2004-02-05 Heavner George A. Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses
WO2004060911A2 (fr) 2002-12-30 2004-07-22 Amgen Inc. Polytherapie a facteurs costimulants
EP2261244A3 (fr) 2003-04-15 2011-02-23 Glaxosmithkline LLC Mutants par substitution de l'interluekine 18 humaine et ces conjugués
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
AU2005277404A1 (en) 2004-08-20 2006-03-02 Smithkline Beecham Corporation Methods of healing wounds by administering human IL-18
TWI422387B (zh) 2006-05-25 2014-01-11 Glaxo Group Ltd 免疫球蛋白
PE20090190A1 (es) 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
US8168165B2 (en) 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
US20120308564A1 (en) 2010-02-09 2012-12-06 Andrew Ian Bayliffe Treatment of a metabolic disorder
US9376489B2 (en) 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules
KR101940430B1 (ko) 2014-08-07 2019-01-18 가꼬우호우징 효고 이카다이가쿠 Il-18과 분자 표적 항체를 병용하는 암 치료약

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
JP3230531B2 (ja) * 1991-08-08 2001-11-19 光信 佐藤 ＩＦＮ―γ誘導活性物質
DE69519454T2 (de) * 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen

Also Published As

Publication number Publication date
AU3779695A (en) 1996-05-23
DE69520088T2 (de) 2004-07-29
TW581771B (en) 2004-04-01
EP0712931B2 (fr) 2006-04-19
EP0712931B1 (fr) 2001-02-14
TW464656B (en) 2001-11-21
DE69520088D1 (de) 2001-03-22
EP0712931A3 (fr) 1997-03-26
DK0712931T3 (da) 2001-03-19
AU700948B2 (en) 1999-01-14
DK0962531T3 (da) 2009-10-05
CA2162353A1 (fr) 1996-05-16
DE69535989D1 (de) 2009-09-17
EP0712931A2 (fr) 1996-05-22
ES2156199T3 (es) 2001-06-16
CA2162353C (fr) 2010-04-27
ES2156199T5 (es) 2006-12-16
EP0962531A3 (fr) 1999-12-15
EP0962531B1 (fr) 2009-08-05
ES2329099T3 (es) 2009-11-20
EP0962531A2 (fr) 1999-12-08
DE69520088T3 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
NO910923D0 (no) Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.
DK0729951T3 (da) Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
DK597288D0 (da) Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf
NO955167D0 (no) Monoklonalt anti-
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
NO922155L (no) Peptider og antistoffer som inhiberer integrinligandbinding
NO891334L (no) Supraledende material og fremgangsmaate for dets fremstilling.
NO843294L (no) Monokloklonat antistoff, dets fremstilling og anvendelse
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
FI952506A0 (fi) Puristusventtiili
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
NO893892L (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DK43489D0 (da) Immunotoksin og fremgangsmaade til dets fremstilling
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
NO893474L (no) Flammehemmende midler og fremgangsmaate for anvendelse.
DK270386D0 (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
DK0391407T3 (da) Polypeptid og antibakterielle præparater, der indeholder det
ZA966151B (en) Salt mediated size exclusion chromatography for buffer exchange and protein refolding.
DE69434900D1 (de) Menschliche chemokin-polypeptide
IT234822Y1 (it) Agenda terapeutica